Evidence map›Paper›PMID 30520002›Full record

Observational studyJournal of racial and ethnic health disparities2019

Racial and Ethnic Trends in Prostate Cancer Incidence and Mortality in Philadelphia, PA: an Observational Study.

Charnita Zeigler-Johnson, Scott Keith, Russell McIntire, Tashika Robinson, Amy Leader, Karen Glanz

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Journal of racial and ethnic health disparities, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Charnita Zeigler-JohnsonDepartment of Medical Oncology, Division of Population Science, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. charnita.zeigler-johnson@jefferson.edu.ORCID http://orcid.org/0000-0003-2641-7755
Scott KeithDepartment of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA.
Russell McIntireCollege of Population Health, Thomas Jefferson University, Philadelphia, PA, USA.
Tashika RobinsonCollege of Population Health, Thomas Jefferson University, Philadelphia, PA, USA.
Amy LeaderDepartment of Medical Oncology, Division of Population Science, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Karen GlanzCenter for Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA.
Thomas Jefferson University · USUniversity of Pennsylvania · US

Funding

U.S. Department of Defense W81XWH-15-1-0693
6 · The paper itself

Abstract

backgroundTo learn more about local prostate cancer (PCa) disparities, we conducted descriptive analyses of the role of race and age in PCa using the Pennsylvania Cancer Registry data for Philadelphia (2005-2014).

methodsWe focused on the most prevalent race/ethnic groups: white (33%), black (44%), and Hispanic (9%). Outcomes included PCa rates, tumor stage, and tumor grade. Percent change was used to describe changes in age-adjusted incidence and mortality rates. Frequency tables and logistic regression models were used to describe trends in proportions of advanced PCa by race and time. Race-by-time interaction terms were retained in the models if statistically significant.

resultsPCa incidence was highest for black men over time. Incidence rates declined over time for all race groups (- 28% for white men to - 38% for Hispanic men). PCa mortality rates declined in a less universal manner (- 5% for blacks to - 32% for whites). Each year, odds increased across all race groups for advanced tumor stage (4% each year among white and Hispanic men and 9% each year among black men) and for advanced tumor grade (4% each year among white and black men and 23% each year among Hispanic men). Among younger men, black men experienced significantly increased odds of advanced tumor stage each year (8%) and Hispanics experienced significantly increased odds of advanced tumor grade each year (30%).

conclusionsBlack men remain at highest PCa risk relative to other racial/ethnic groups in Philadelphia. Younger black and Hispanic men are at particular risk for advanced PCa at diagnosis.

Indexed as

AdultAgedAged, 80 and overBlack or African AmericanHispanic or LatinoHumansIncidenceMaleMedical Staff, HospitalMiddle AgedMortalityNeoplasm GradingNeoplasm StagingOdds RatioPhiladelphiaProstatic NeoplasmsPhiladelphiaProstate cancer trendsRace/ethnicity

Identifiers

PMID30520002
OpenAlexW2902400717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.